Gsk (GSK) Work In Process (2013 - 2014)
Gsk (GSK) posted Work In Process of $2.5 billion for Q4 2014, up 8.25% quarter-over-quarter from $2.3 billion in Q4 2013, and up 8.25% YoY from $2.3 billion in Q4 2013.
Powered by 
Analysis
Gsk (GSK) Work In Process (2013 - 2014) Analysis & Trends
Gsk (GSK) has 2 years of Work In Process data on file, last reported at $2.5 billion in Q4 2014.
- For the quarter ending Q4 2014, Work In Process rose 8.25% year-over-year to $2.5 billion; the trailing twelve-month figure through Dec 2014 stood at $2.5 billion (up 8.25% YoY), and the FY2014 full-year result was $2.5 billion, up 8.25% from the prior year.
- Work In Process was $2.5 billion for Q4 2014 at Gsk, up from $2.3 billion in the prior quarter.
- In the past five years, Work In Process ranged from a high of $2.5 billion in Q4 2014 to a low of $2.3 billion in Q4 2013.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Asml Holding | 618.10 Bn | 602.12 Bn | 5.90 Bn |
| 2 | Hsbc Holdings | 361.12 Bn | 361.12 Bn | - |
| 3 | General Electric | 329.26 Bn | 319.92 Bn | 6.95 Bn |
| 4 | Astrazeneca | 253.70 Bn | 248.42 Bn | 12.86 Bn |
| 5 | Citigroup | 227.85 Bn | -2,074.45 Bn | 24.75 Bn |
| 6 | Bhp | 215.89 Bn | 197.35 Bn | - |
| 7 | Rio Tinto | 203.71 Bn | 199.33 Bn | - |
| 8 | Diageo | 197.31 Bn | 195.28 Bn | - |
| 9 | Unilever | 139.11 Bn | 132.08 Bn | - |
| 10 | Gsk | 101.46 Bn | 101.46 Bn | 15.97 Bn |